BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Sanjit Agarwal talks to ecancer at the Choosing Treatments Wisely event in Kolkata about breast cancer screening in India.
He describes that there is no national screening program currently and most patients are being diagnosed with advanced disease.
Dr Agarwal states that mammography is not a feasible method, due to the large population of India and explains the government initiated 'Ayushman Bharat' scheme which has helped several women receive clinical breast examinations in attempt to detect breast cancer early.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Transforming cancer care in India: The Access Cancer Care Initiative
Addressing Breast Cancer Disparities in Africa
Powering equity in cancer care through digital health
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Choosing Wisely in radiology Tanzania
The use of IORT at Universitätsmedizin Mannheim hospital
Lung cancer screening and treatment in the Philippines
Choosing Wisely to mitigate financial toxicity in cancer care in Africa